Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Zirdu who wrote (4036)	6/6/2001 12:39:21 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 52153

Hi RRanney, I think (not certain) that SloNiacin has had some liver tox issues and that it was taken off the VA formulary. Check it out before trying it - admittedly I get facts screwed up at times. ij

To: Zirdu who wrote (4036)	6/6/2001 12:52:04 PM
From: Michael Young	Read Replies (1) \| Respond to of 52153

Nope, those OTC Niacin supplements can present severe toxicity/flushing issues. KOSP spent a lot of time and money developing a version of niacin that reduced those problems. In fact, the bad reputation of niacin has been a hurdle for KOSP to overcome. Many DRs just assume that all versions of niacin present serious patient compliance issues. Fortunately, word is finally getting around. My father's Dr refused to consider Niaspan a few years back. But he changed his tune in the past year. MIKE